Full-stack Engineer
Save this job and keep your search organized
Create a free account to save jobs, create alerts and return to this listing from your dashboard.
By continuing, you agree to our Terms & Privacy Policy.
QAI Labs Ltd. is a Delaware corporation headquartered in Sugar Land, Texas, with an Asia-Pacific origination footprint. We hire for technical depth and editorial taste. Open roles below;
Why QAI Labs QAI Labs is building NOVA-3, a computer-aided design platform for multi-specific antibodies — at the layer where molecular design decisions are made, not downstream of them. We are early-stage and intentional about it: the team is small, the problems are real, and the design choices you make now will be in the platform for years. If you want to work somewhere that takes scientific honesty and engineering craft seriously from the start, this is that company.
Sit between the generator stack (Boltz-2, Chai-1, RFdiffusion) and the three NOVA-3 program-specific heads (ranking, structural confidence, in-silico Kd). You should be comfortable with PyTorch, with reading recent antibody and protein design literature, and with the engineering reality of running benchmarks that other people will reproduce. Structural biology background or strong ML-for-biology track record required.
Build and manage partner conversations across Japan, Korea, and Southeast Asia
Qualify licensing, co-development, and platform access opportunities at early stage
Lead partner-facing technical presentations alongside the science team
Own deal pipeline tracking and surface high-priority conversations to founders
Requirements Prior BD or licensing experience in pharma or biotech
Able to engage credibly on antibody biology or adjacent modalities
Comfortable representing a pre-revenue, early-stage company
APAC network in pharma R&D or licensing an advantage
IND-readiness
· CMC strategy
· Phase 2 hire Will own regulatory strategy across our in-licensed programs as they move toward IND-readiness, including FDA and EMA interaction planning and CMC documentation strategy. Open at Phase 2;
Will run the wet-lab side of the data flywheel — partner-lab coordination, assay QC, sample logistics, and the data-back-into-platform pipeline that feeds NOVA-Evidence. Open at Phase 2;
We are a small, early-stage team. Every hire shapes the company. We don't have a big HR department — if you're right, we'll know quickly.
#J-18808-Ljbffr QAI Labs Ltd.